基于mRNA的HIV-1疫苗
Shamim Ahmed1, Alon Herschhorn1,2,3,4,5,6,7
1Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Clinical microbiology reviews
|July 17, 2024
概括
针对严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 取得成功的信使RNA (mRNA) 疫苗,目前正在针对人类免疫缺陷病毒1型 (HIV-1) 开发. 这些新的HIV-1 mRNA疫苗正在临床前和临床试验中,以克服免疫逃避挑战.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) mRNA疫苗的成功刺激了人们对开发其他传染病的mRNA技术的兴趣.
- 人类免疫缺陷病毒1型 (HIV-1) 由于其快速突变率和免疫规避策略,对疫苗开发提出了重大挑战.
- 尽管进行了数十年的研究,但有效的HIV-1疫苗仍然难以捉摸.
研究的目的:
- 审查目前开发基于mRNA的HIV-1疫苗的战略.
- 讨论HIV-1 mRNA疫苗候选人的各种准方法.
- 总结最近的发现和HIV-1 mRNA疫苗开发的未来前景.
主要方法:
- 关于在动物模型中制造和测试基于mRNA的HIV-1疫苗的临床前研究的审查.
- 对HIV-1 mRNA疫苗正在进行和计划进行的临床试验的分析.
- 对mRNA疫苗的不同抗原向策略和输送系统的检查.
主要成果:
- 已经开发了多种基于mRNA的HIV-1疫苗候选剂,并在各种动物模型中进行了测试.
- 已启动早期临床试验,计划进行更多的临床试验,以评估这些疫苗的安全性和免疫性.
- 优化mRNA疫苗的设计和交付对于克服HIV-1的免疫逃避机制至关重要.
结论:
- mRNA疫苗技术有望开发一种有效的HIV-1疫苗.
- 解决HIV-1复杂的免疫逃避策略对于疫苗的成功至关重要.
- 持续的研究和临床评估对于推进HIV-1 mRNA疫苗开发至关重要.
更多相关视频
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
7.8K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
相关概念视频
Vaccinations
Overview
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
